English

Nordic Nanovector ASA (OSE: NANO) – MANDATORY NOTIFICATION OF TRADE

Report this content

Oslo, Norway 27 October 2015:

Jostein Dahle, who is the Chief Scientific Officer of Nordic Nanovector ASA, purchased yesterday 3,800 shares in Nordic Nanovector ASA at an average share price of NOK 13.16 per share.

Following the transaction, Jostein Dahle and his close associate hold 254,958 shares in Nordic Nanovector ASA. Jostein Dahle holds 125,000 share options in Nordic Nanovector ASA.

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.



Tags:

Cancer Therapy non-hodgkins lymphoma Betalutin Nordic Nanovector Radioimmunotherapy Roy Hartvig Larsen anticancer therapeutics

Subscribe